Amish Shah, MD is an emergency physician at Dignity Health and a member of the Arizona House of Representative elected by the people of LD24 – Central Phoenix and South Scottsdale. On Sunday, June 14, 2020, Dr. Shah shared the message below via Facebook. With his permission, we are sharing it with you.
Category Archives: AZBio News
New Report Examines Bioscience Industry’s Economic Impact in Arizona & Role in Global Pandemic
Chandler, Arizona – The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States. The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint across the nation and in Arizona, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.Continue reading
ICYMI – Great BIO Digital Sessions Available Online
Select Sessions From BIO Digital Week Now Available!Continue reading
Pediatric experts warn against delaying well-child visits
CDC reports drop in recommended child vaccinationsContinue reading
Humabiologics Inc. Reaches $1M Seed Round Funding Milestone
PHOENIX, Ariz.– Humabiologics Inc., a regenerative medicine company founded by scientists and tissue industry experts, announced today it has successfully raised $1 million in seed funding.Continue reading
RCT Acquires Translational Drug Development, LLC
Tucson, Ariz. & Scottsdale, Ariz. / June 4, 2020
Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization.
TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovative oncology-focused companies.Continue reading
IMNA Announces New Appointment to Its Board Of Directors
IMNA Solutions announced today that it has appointed Russ Yelton, President/CEO of Yelton and Associates and Chairman of The Board of Trustees of AZAdvances to its board of directorsContinue reading
ASU develops state’s first saliva-based COVID-19 test
In an effort to make COVID-19 diagnostic testing easier and more readily available to Arizonans, researchers at Arizona State University have developed the state’s first saliva-based test.Continue reading
Kalos therapeutics announces important progress in therapeutic peptide for cancer program
Kalos therapeutics is developing a novel, small peptide with activity against human pancreatic cancer
Continue reading
Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19
- Study Demonstrates 5-Day Treatment Course of Remdesivir Resulted in Significantly Greater Clinical Improvement Versus Treatment with Standard of Care Alone
- Data Add to Body of Evidence from Prior Studies Demonstrating Benefit of Remdesivir in Hospitalized Patients with COVID-19